Bioceres Crop Solutions Corp. (NASDAQ:BIOX – Get Free Report)’s stock price traded up 8.5% during trading on Thursday . The company traded as high as $0.45 and last traded at $0.4499. Approximately 123,992 shares were traded during trading, a decline of 21% from the average session volume of 155,976 shares. The stock had previously closed at $0.4147.
Analyst Upgrades and Downgrades
Separately, Weiss Ratings downgraded shares of Bioceres Crop Solutions from a “sell (d)” rating to a “sell (d-)” rating in a research note on Monday, July 13th. One investment analyst has rated the stock with a Buy rating, two have issued a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat, Bioceres Crop Solutions has an average rating of “Hold” and a consensus target price of $4.00.
Check Out Our Latest Stock Report on BIOX
Bioceres Crop Solutions Stock Performance
Institutional Inflows and Outflows
A number of institutional investors have recently added to or reduced their stakes in the business. Marshall Wace LLP increased its position in Bioceres Crop Solutions by 180.0% during the 4th quarter. Marshall Wace LLP now owns 595,410 shares of the company’s stock valued at $780,000 after purchasing an additional 382,744 shares during the period. GAM Holding AG purchased a new stake in shares of Bioceres Crop Solutions in the 4th quarter worth approximately $655,000. Ardsley Advisory Partners LP boosted its stake in shares of Bioceres Crop Solutions by 691.7% during the fourth quarter. Ardsley Advisory Partners LP now owns 475,000 shares of the company’s stock valued at $622,000 after purchasing an additional 415,000 shares in the last quarter. Susquehanna International Group LLP bought a new position in shares of Bioceres Crop Solutions during the third quarter valued at approximately $315,000. Finally, State of Wisconsin Investment Board bought a new position in shares of Bioceres Crop Solutions during the fourth quarter valued at approximately $247,000. Hedge funds and other institutional investors own 17.68% of the company’s stock.
About Bioceres Crop Solutions
Bioceres Crop Solutions Corp. is an agricultural biotechnology company focused on developing, manufacturing and commercializing a range of crop inputs designed to enhance yields and improve sustainability. The company’s portfolio includes biological seed treatments, inoculants for nitrogen fixation, specialty fertilizers and proprietary biopesticides, which are formulated to support plant health and resilience under varying environmental conditions.
Among its flagship offerings is the HB4 drought-tolerant wheat technology, the first genetically modified wheat developed to withstand water stress, which has received regulatory approval in several markets.
See Also
- Five stocks we like better than Bioceres Crop Solutions
- 3 Energy Stocks Raising Dividends as the Sector Surges
- 5 Reasons the S&P 500 Could Keep Rallying Through Year-End
- Walmart’s Post-Earnings Drop Could Be a Buying Opportunity
- The Trade Desk’s Earnings Miss Raises a Bigger Question About Its AI Future
Receive News & Ratings for Bioceres Crop Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bioceres Crop Solutions and related companies with MarketBeat.com's FREE daily email newsletter.
